National Working Group on Microbicides RECTAL MICROBICIDES RESEARCH CURRENT STATUS & CHALLENGES Dr. Badri N. Saxena, M.D., F.A.M.S. Professor, Centre for.

Slides:



Advertisements
Similar presentations
Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
Advertisements

What is up with Nonoxynol-9? Global Campaign for Microbicides
Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
HIV CENTER for Clinical and Behavioral Studies MAIN POINTS ACKNOWLEDGMENTS This research was supported by a NIMH grant (R ; PI, Alex Carballo-Diéguez,
Rectal microbicides Bridget Haire International Rectal Microbicides Advocates (IRMA)
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
Rectal microbicides An update Gus Cairns.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
What is the risk of acquiring HIV from oral sex? Workshop Ground Rules Confidentiality Use “I” statements Pass if you want Agree to Disagree Leave PC.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Use of Antivirals in Prevention Oral and Topical Prophylaxis
Optimism or pessimism in microbicides research? Anatoli Kamali MRC/UVRI Uganda Research Unit on AIDS.
Rectal Lubricant Use & Incident STIs at 9 US STD Clinics 1 UCLA Fielding School of Public Health, 2 UCLA David Geffen School of Medicine, 3 Dept. of Epidemiology.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
The 4 th Decade of the HIV Epidemic: Midwest Regional Response September 17, 2013 with Jim Pickett, AFC/IRMA The Bottom Line on Rectal and Vaginal Microbicide.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
1 Are Lubes Safe for Rectal Use? Next Steps for Researchers and Advocates Marc-André LeBlanc, Jim Pickett, Charlene Dezzutti, Edward Fuchs, Pamina Gorbach,
Rectal Microbicides: The Basics October 2008, ESM Marc-André LeBlanc, GCM.
Microbicide Research: A Promising HIV/AIDS Prevention Strategy for Women Roberta Black, Ph.D. Division of AIDS, National Institute of Allergy and Infectious.
Bheki Sithole 30 Nov Sibayeni Lodge Most at Risk Behavior Populations (MSM): Feedback, Challenges and Experiences.
Use and acceptability of biomedical HIV prevention technologies among MSM and MSW in Vietnam Donn Colby, MD, MPH Harvard Medical School AIDS Initiative.
Introduction to HIV New Prevention Technologies (NPTs)
Rectal Microbicides: New Hope for Non-Condom Prevention of HIV and other STDs.
State of Global Rectal Microbicide Research Ian McGowan MD PhD FRCP Magee-Womens Research Institute University of Pittsburgh.
DEVELOPING DUAL COMPARTMENT MPTS THAT WORK UP FRONT AND FROM BEHIND José Fernández Romero Population Council September 9, 2015.
Rectal Behaviors: a global overview Shauna Stahlman & Pamina M. Gorbach UCLA Department of Epidemiology.
Jesse L. Clark 1, Jerome T. Galea 1, Hector J. Salvatierra 2, Kelika A. Konda 1, Alex Carballo-Dieguez 3, Thomas J. Coates 1, Carlos F. Caceres 2 1. Department.
Rectal Microbicides: New Hope for HIV and STD Prevention.
Microbicides: What will they do? What will they be like? What needs to be done? Richard A. Cone Johns Hopkins University ReProtect, LLC (“BufferGel™” &
Prevalence and Types of Rectal Douches used for Anal Intercourse: Results from an International Survey Marjan Javanbakht Shauna Stahlman Jim Pickett Marc-André.
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
Moving the Rectal Microbicide Agenda Forward; Results from a Scientific, Ethical, and Community Consultative Process Ian McGowan MD PhD FRCP University.
UK Campaign for Microbicides Rectal microbicides Need, development and advocacy Kim Mulji Executive Director Naz Foundation.
The Microbicide Trials Network Group 3 Lindsay O. Bryant Danielle M. Campbell Alan D. Johnson Leroy Smith Jr. Kendra M. Taylor May 31, 2016.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
Rectal microbicides, where are we? Kim Mulji Naz Foundation International.
JOSEPH O’REILLY Deputy Chief Executive REBEKAH WEBB Policy Officer IN COLLABORATION WITH THE GLOBAL CAMPAIGN FOR MICROBICIDES IS THERE AN INVISIBLE CONDOM.
Microbicides A Scientific Update
Implications of Anal Intercourse and Rectal use of Products in Vaginal Microbicide Trials Ian McGowan MD PhD FRCP.
Welcome South Africa 4 Rectal Microbicides A Stakeholder Consultation on Rectal Microbicide Research and Advocacy Please sign in.
A Jo Robinson, Terrence Higgins Trust in cooperation with the Global Campaign for Microbicides Topical.
Microbicides The Population Council Experience and Future Directions Don E. Waldron Medical Director Don E. Waldron Medical Director.
Gel or Suppositories? Results of a Rectal Microbicide Formulation Preference Trial Alex Carballo-Diéguez 1, Curtis Dolezal 1, Jose A. Bauermeister 1, Ana.
Measuring Anal Intercourse in Vaginal Microbicide Studies/Trials
Rectal microbicides advocacy Issues, work and collaboration Kim Mulji UK rectal microbicides working group.
A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009.
Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.
What are you into? The role of social networking platforms in HIV risk behavior Darren Whitfield, MSW, Doctoral Student University of Denver, Graduate.
Microbicides: New Hope for Prevention of HIV and other STIs Your name here
Adapted and reproduced with permission from Alberta Health Services
International AIDS Conference
Information about HIV Prevention Options
Rectal Microbicides Ian McGowan MD PhD FRCP
Regulatory Considerations for Approval: FDA perspective
Dual Protection = prevent pregnancy + avoid STI/HIV
Module 4 (c) Stopping PrEP
Rectal Microbicides: Where We’re Heading
Adapted and reproduced with permission from Alberta Health Services
The HIV Prevention Landscape
Rectal Microbicide Development: - How Did We Get Here
The Double Delights of Douching
Rectal Gels for PrEP Are They an Option?
José Bauermeister PhD, MPH University of Pennsylvania MTN BRWG Member
Rectal Microbicide Protocol Status
Rectal Microbicides: New Hope for HIV and STD Prevention
Presentation transcript:

National Working Group on Microbicides RECTAL MICROBICIDES RESEARCH CURRENT STATUS & CHALLENGES Dr. Badri N. Saxena, M.D., F.A.M.S. Professor, Centre for Policy Research, New Delhi Advisor, Indian Council of Medical Research, New Delhi Rectal Microbicides Advocacy November 29, 2006

National Working Group on Microbicides RECEPTIVE ANAL INTERCOURSE (RAI) RAI is a risk factor for HIV infection for both men and women LACK OF RELIABLE DATA in India and globally 30% heterosexuals in some cultures engage in RAI Sex workers and women with substance abuse more vulnerable Total volume and numbers of unprotected RAI is 5 times higher in heterosexuals as compared to MSM THUS BOTH WOMEN AND MEN NEED RECTAL MICROBICIDES

National Working Group on Microbicides HIV PREVENTION TECHNOLOGIES Condom effective but not sufficient Need another technology e.g. microbicides Potential impact of Rectal microbicides Mathematical modeling by UCLA group 50% effective microbicide used in 50% of RAI would reduce the new infection by 13%

National Working Group on Microbicides Current status Very few human studies to date and published studies only on N-9 Several vaginal products have been evaluated in pig- tailed macaque model by Dorothy Patton Nonoxynol-9 found to be profoundly toxic in this model (Sexually Transmitted Disease, 2002, 29:581) Investigators still trying to figure out “how” to conduct and evaluate phase I studies appropriately

National Working Group on Microbicides

Basic Colorectal Anatomy Length of colorectal column: 30 feet!

National Working Group on Microbicides Physiological Differences VaginaRectum Most of the epithelium is 40 cell layers thick Very fragile epithelium, 1 cell layer thick. Fewer CD4 cells than rectumMore inflammatory cells under surface (CD4 receptors) Acidic pHAlkaline, rather than acidic pH Enclosed pouchOpen-ended tube

National Working Group on Microbicides What happened to N-9? Work with N-9 as a potential microbicide ceased CDC issued guidance saying that N-9 should not be recommended for HIV prevention or included in “hierarchical” messages and N-9 lubricated condoms should no longer be recommended WHO advised against N-9 for disease prevention. N-9 only recommended as a contraceptive option for women not at risk of HIV

National Working Group on Microbicides Nonoxynol-9 and rectal sex David Phillips, et al. found that even low doses of N-9 caused massive sloughing of the rectal epithelium (n=4 people). Findings duplicated in large sample Rectal epithelium heals quickly – less than 8 hours Damage associated with rectal use of N-9 is far more extensive than observed with vaginal use of products Rectal exposure to N-9 increases transmission of HSV in mice and monkeys

National Working Group on Microbicides Gay men are still seeking out N-9 Among a diverse sample of 573 MSM in San Francisco, 67% had used N-9 in the past year This was after CDC issued warnings and the San Francisco DOH undertook outreach activities Among those who had used N-9 in the last year: -41% used it without a condom because they thought the N-9 might be protective

National Working Group on Microbicides ONGOING RESEARCH: PRE- CLINICAL ASPECTS Which elements of intestinal mucosa are the initial targets of HIV infection? Which regions of colon need safeguarding ? Semen simulant can travel 2-3 feet into colon. How to deliver rectal microbicides ? Foams / enemas / suppositories ? What are the biomarkers for safety testing – in vitro / in vivo systems Proof of concept: Macaque model for SHIV / SIV infections (CVN study) Minimum effective dose/ bioavailability / distribution Ongoing discussion about whether rectal safety testing should be done for all vaginal microbicides

National Working Group on Microbicides ONGOING RESEARCH: BEHAVIOURAL RESEARCH Sexual behavioral studies amongst women and men engaged in RAI User acceptability of rectal microbicides Use of products on a continued basis

National Working Group on Microbicides Research in action Laboratory studies: Dr. Ian McGowan, HPTN 056, University of California/Los Angeles Defining measurements that can be made on rectal tissue biopsies that would be of use in rectal microbicide safety studies. Distribution studies: Dr. Craig Hendrix at Johns Hopkins University, MD Volunteers simulated anal intercourse MRI scans done up to five hours after its release Initial studies suggest that semen could travel up to 60 centimeters Showed where a microbicide would be needed to protect vulnerable tissues

National Working Group on Microbicides Behavioral research in action: Alex Carballo-Diéguez, Columbia Univ,NY Ken Mayer, Fenway Community Health, Boston Maximum acceptable dose for insertion and anal Intercourse Alex Carballo-Diéguez & Sigma Research Center Surveys of MSM interest in using microbicide San Francisco: 59% heard of microbicides, 25%-35% might use (depending on stated effectiveness) UK: 23% had heard of microbicides, 59% might use

National Working Group on Microbicides ONGOING RESEARCH: CLINICAL ASPECTS PHASE 0 Baseline studies of injury and inflammation in rectum amongst men and women during typical RAI Male tolerance: Penile and urethral irritation of potential Rectal Microbicide

National Working Group on Microbicides ONGOING RESEARCH : CLINICAL TRIALS PHASE 1 Safety studies RTI product: PMPA / a form of Tenofovir NNRTIs: TMC 120-Dapvirin, UMC 781 Entry Inhibitors: Pro-2000 Dendrimer polyanion; VivaGel All vaginal microbicides to be studied

National Working Group on Microbicides Patton rectal safety study summary ProductMicroflora changesDisruption of epithelium N Carraguard - - Savvy - - Vivagel - - Buffer gel - - Microbicides 2006: Poster 110

National Working Group on Microbicides Patton rectal safety study summary ProductMicroflora changesDisruption of epithelium Cellulose suflate - - UC Polystyrene sulfonate - - Octyglycerol - - Microbicides 2006; Poster 110

National Working Group on Microbicides Rectal Safety of Vaginal Microbicides CandidateMurinePrimateExplantHuman N-9+++ Buffer gelNeg ?? Savvy?Neg?? CarraguadNeg ?? Cellulose sulfate?Neg?? Pro-200??Neg? SPL 7013?Neg?? TMC 120??Neg? PMPA?Neg ? UC781Neg ? Octyglyceral?Neg??

National Working Group on Microbicides Rectal microbicides expenditures:

National Working Group on Microbicides

THANK YOU